Permeon Biologics, Inc. (extinct)

Permeon Biologics, Inc. (extinct)

Permeon Biologics, Inc. (extinct)

Date Founded



1 Kendall Square,Building 1400 West,Suite 14203,Cambridge, MA 02139

Type of Company


Employees (Worldwide)

11 - 50


Hospitals & Patient Services

Company Description

Permeon Biologics, Inc. develops intracellular biotherapeutics platform to enhance drug delivery. Its intraphilin technology platform leverages research on remodeling the surfaces of proteins to permit cell penetration without losing their structure or activity; and enables functional proteins to replace or restore defective pathways inside cells that cause disease. The company was founded by Douglas G. Cole, David R. Liu, John W. Ripple, and Noubar B. Afeyan in 2008 and is headquartered in Cambridge, MA.

Paths to Permeon Biologics, Inc.
Potential Connections via
Relationship Science
Permeon Biologics, Inc.
Recent Transactions
Details Hidden

Permeon Biologics, Inc. raised money in a private placement transaction

Details Hidden

Chief Executive Officer & Director at Exonics Therapeutics, Inc.

Details Hidden

Co-Founder at Moderna, Inc.

Details Hidden

Founder at Editas Medicine, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Permeon Biologics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Permeon Biologics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Permeon Biologics, Inc..